
Bodal Chemicals Q1 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- The company is on a growth trajectory across all divisions, with room to improve volumes in dyestuff and dye intermediates.
- Basic Chemicals is operating at about 90% capacity with no volume expansion scope.
- Benzene derivatives production and sales are expected to start contributing significantly this month.
- Target to reach 80%-90% volume utilization in benzene derivatives within 2-3 months.
- Benzene derivatives are expected to contribute Rs. 100-125 crores in topline during the second half of FY '25, assuming 60%-70% utilization.
- Chlor-Alkali capacity utilization has room for 5%-10% improvement, supporting volume growth.
- Overall, maintaining EBITDA around Rs. 35 crores is achievable and is expected to improve in coming quarters.
- Gradual improvement in Chlor-Alkali demand due to its use across chemical and pharma sectors is anticipated.
See what Bodal Chemicals management said on margin guidance — free account, 30 seconds.
Fundraise plans
- No specific mention of new fundraising through debt or equity in the earnings call transcript.
- The company is focusing on repaying term loans quarterly, which is expected to reduce interest costs.
- Interest costs peaked in Q1 FY25 and are expected to reduce going forward, with full-year interest guidance around Rs. 74-75 crores.
- There is no indication of additional borrowing or equity issuance planned in the near term.
- The company is leveraging internal projects like the Saykha greenfield project to enhance production and revenues rather than seeking new external funding.
See what Bodal Chemicals management said on order book — free account, 30 seconds.
Capex plans
YesTrack Bodal Chemicals — get its next earnings analysis in your feed
How does Bodal Chemicals rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Bodal Chemicals rank in Chemicals & Petrochemicals?
Compare Bodal Chemicals against every Chemicals & Petrochemicals company (Q1 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Bodal Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…